The effect of lipophilicity and dose on the frequency of statin-associated muscle symptoms: A systematic review and meta-analysis
- 1 February 2018
- journal article
- review article
- Published by Elsevier in Pharmacological Research
- Vol. 128, 264-273
Abstract
No abstract availableKeywords
This publication has 62 references indexed in Scilit:
- A Survey of the FDA's AERS Database Regarding Muscle and Tendon Adverse Events Linked to the Statin Drug ClassPLOS ONE, 2012
- Individualized Risk for Statin-Induced Myopathy: Current Knowledge, Emerging Challenges and Potential SolutionsPharmacogenomics, 2012
- Treating statin-intolerant patientsDiabetes, Metabolic Syndrome and Obesity, 2011
- Effects of Statins on Skeletal Muscle: A Perspective for Physical TherapistsPhysical Therapy, 2010
- Drug-related Myopathies of Which the Clinician Should Be AwareCurrent Rheumatology Reports, 2010
- Rosuvastatin to Prevent Vascular Events in Men and Women with Elevated C-Reactive ProteinNew England Journal of Medicine, 2008
- Safety and Efficacy of Statins in AsiansThe American Journal of Cardiology, 2007
- Toxicity of statins on rat skeletal muscle mitochondriaCellular and Molecular Life Sciences, 2006
- Measuring inconsistency in meta-analysesBMJ, 2003
- Meta-analysis in clinical trialsControlled Clinical Trials, 1986